Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02268084 · ClinicalTrials.gov registry record · NA
Trial to Evaluate Efficacy of Magnetic Resonant Therapy (MRT) in PTSD
A NA study, sponsored by Wave Neuroscience.
- Completed
- Registry status
- NA
- Development phase
- 96
- Enrollment target
NCT02268084 is a NA study that has completed, run by Wave Neuroscience. The registered enrollment target is 96 participants.
The verdict
NCT02268084, a NA study, has completed, sponsored by Wave Neuroscience.
- COMPLETED
- Registry status
- NA
- Development phase
- 96 participants
- Enrollment target
Study Summary
The purpose of this study is to establish the efficacy of Magnetic Resonant Therapy in treating Post Traumatic Stress Disorder in Veterans.
Interventions
- DEVICE Sham
- DEVICE Magnetic EEG/ECG-guided Resonance Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2014-10 |
| Est. Completion | 2016-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02268084
The ClinicalTrials.gov registry entry for NCT02268084 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wave Neuroscience, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham is the first listed.
NCT02268084 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02268084 about?
NCT02268084 is a clinical study titled "Trial to Evaluate Efficacy of Magnetic Resonant Therapy (MRT) in PTSD". The purpose of this study is to establish the efficacy of Magnetic Resonant Therapy in treating Post Traumatic Stress Disorder in Veterans.
What is the current status of trial NCT02268084?
This trial is currently completed. It is a NA study. The enrollment target is 96 participants. The study started on 2014-10. Estimated completion is 2016-10.
What interventions are being tested in trial NCT02268084?
The interventions under investigation include: Sham (DEVICE), Magnetic EEG/ECG-guided Resonance Therapy (DEVICE).
Who is sponsoring clinical trial NCT02268084?
This trial is sponsored by Wave Neuroscience, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.